Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression. [electronic resource]
Producer: 20030220Description: 409-16 p. digitalISSN:- 1522-8002
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Blotting, Western
- Breast Neoplasms -- drug therapy
- Cell Division -- drug effects
- Choline -- metabolism
- Cyclooxygenase 1
- Cyclooxygenase 2
- Epithelial Cells -- metabolism
- Female
- Glycerylphosphorylcholine -- metabolism
- Humans
- Indomethacin -- pharmacology
- Isoenzymes -- metabolism
- Magnetic Resonance Spectroscopy
- Membrane Proteins
- Monomeric GTP-Binding Proteins -- metabolism
- NM23 Nucleoside Diphosphate Kinases
- Nucleoside-Diphosphate Kinase
- Phosphorylcholine -- metabolism
- Prostaglandin-Endoperoxide Synthases -- metabolism
- Transcription Factors -- metabolism
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.